Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
NCT03657745
Alzheimer Disease, Brain Diseases
Miami, Florida, United States
View Trial DetailsNCT Number: NCT05481749
Neuropsychological tests currently considered to evaluate the cognitive performance of the oldest-old population (more than 80 years) are not adapted to this group population. This trial aims to determine the normal limits for this group population of a set of 18 neuropsychological test. Results may improve the diagnostic cognitive evaluation of this population.
Interested in participating?
Request Info80 year and older
All sexes
Observational
Centro de Salud Les Roquetes-Sant Pere de Ribes, Sant Pere de Ribes, Barcelona, Spain
120 subjects more than 80y old (non-institutionalized) grouped in 4 age categories (80-84, 85-89, 90-94, 95 or more) will be evaluated through 18 neuropsychological tests (usually considered at Memory Clinics).
Subjects will be recruited from 5 Primary Care Centers by a random selection method (stratified by age group).
Normal limits will be defined by the percentiles of test punctuation. Previously, punctuation will be adjusted by age and education level by lineal regression.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: This outcome will be evaluated at Memory Clinic Unit, following the enrollment visit. The evaluation of this outcome will last approximately 60 minutes.
Cognitive performance will be evaluated by 18 neuropsychological test (quantitative scores) which cover all main cognitive domains (memory and learning, language, perceptual-motor abilities, executive functions and attention).
Contact information is provided by the study sponsor or research team.
César Gálvez-Barrón, Ph.D.
CONTACT
Noemi Casaponsa
CONTACT
Consorci Sanitari de l'Alt Penedès i Garraf
Other
Neuropsychological Assessment Of The Non-institutionalized Oldest-Old Population. Multicenter Normative Study.
Acronym: NEUROPSIC-GR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03657745
Alzheimer Disease, Brain Diseases
Miami, Florida, United States
View Trial DetailsNCT04693611
Brain Diseases, Central Nervous System Diseases
Ribeira de Fráguas, Albergaria-a-Velha, Portugal
View Trial DetailsNCT03246269
Alzheimer Disease, Brain Diseases
View Trial DetailsNCT02014246
Brain Diseases, Central Nervous System Diseases
Baltimore, Maryland, United States
View Trial Details